These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6650284)

  • 1. Treatment of a murine leukemia with chlorambucil bound monoclonal antibodies.
    Feinerman B; Paul RD; Feinerman G
    Adv Exp Med Biol; 1983; 166():59-66. PubMed ID: 6650284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.
    Dye ES; North RJ
    J Leukoc Biol; 1984 Jul; 36(1):27-37. PubMed ID: 6234371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytotoxic activity in mouse tumors by lymphocytes with anti-streptococcal specific antibodies].
    Fujioka T; Tanji S; Koike H; Kumagai K; Aoki H; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1243-7. PubMed ID: 3068321
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor effect of Nocardia rubra cell wall skeleton on syngeneically transplanted P388 tumors.
    Izumi S; Ogawa T; Miyauchi M; Fujie K; Okuhara M; Kohsaka M
    Cancer Res; 1991 Aug; 51(15):4038-44. PubMed ID: 1855218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations.
    Fleischmann WR; Kleyn KM; Baron S
    J Natl Cancer Inst; 1980 Nov; 65(5):963-6. PubMed ID: 6159498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytometric study of the effects of destruxin E on leukemic cells in mice].
    Odier F; Vago P; Quiot JM; Devauchelle G; Bureau JP
    C R Acad Sci III; 1987; 305(14):575-8. PubMed ID: 3121146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of chlorambucil activity by phenylbutazone.
    Schiffman FJ; Uehara Y; Fisher JM; Rabinovitz M
    Cancer Lett; 1978 Apr; 4(4):211-6. PubMed ID: 647661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; Johnson MA; Moeller RB; Wallace TL
    Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
    Kirch ME; Hammerling U
    J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins.
    Marches R; Mota G; Margineanu M; Stavri H; Savi G; Nicolae M; Bancu A; Moraru I
    Neoplasma; 1990; 37(5):573-8. PubMed ID: 2234217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P; Panasci LC
    Cancer Res; 1987 Oct; 47(19):5102-7. PubMed ID: 3621195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
    Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
    Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperthermia and X-irradiation on survival and occurrence of metastases in mice bearing P388 tumor.
    Perlaky L; Fónagy A; Unger E; Hidvégi EJ
    Int J Hyperthermia; 1989; 5(5):603-15. PubMed ID: 2768895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.
    Bernstein ID; Tam MR; Nowinski RC
    Science; 1980 Jan; 207(4426):68-71. PubMed ID: 6965328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of testosterone on growth of P388 leukemia cell line in vivo and in vitro. Distribution of peripheral blood T lymphocytes and cell cycle progression.
    Aboudkhil S; Henry L; Zaid A; Bureau JP
    Neoplasma; 2004; 51(5):368-74. PubMed ID: 15640941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.